Home/Smart Money/General Catalyst Group Management, LLC
§ 13F · FUND PROFILE

General Catalyst Group Management, LLC.

AUM · $3.0B (13F)Positions · 8Turnover · n/a · Q2Filed · Aug 17, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$60M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 17, 2026
#TickerNameShares$ value% portΔ Q2
1AVBPArriVent BioPharma, Inc.1.49M$52M27.5%±0%
2PBLSParabilis Medicines, Inc.1.60M$44M23.2%NEW
3CARTMaplebear, Inc.711K$34M17.9%±0%
4MAZEMaze Therapeutics, Inc.1.04M$31M16.4%±0%
5ODTXOdyssey Therapeutics, Inc.810K$15M8.0%NEW
6EIKNEikon Therapeutics, Inc.305K$4M2.1%±0%
7GUTSFractyl Health, Inc.4.88M$4M2.1%±0%
8LIFEEthos Technologies, Inc.74K$1M0.7%±0%
9CPNGCoupang Inc.55K$950K0.5%+49%
10AMZNAmazon.com Inc.4K$925K0.5%+50%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE GENERAL SIGNAL

AC read

General Catalyst Group Management, LLC is a Other fund managing $3.0 billion in assets. The fund runs a focused portfolio of just 8 positions.

Read the full dossier →